Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moreno-Lopez, B.
Right arrow Articles by Delgado-Garcia, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moreno-Lopez, B.
Right arrow Articles by Delgado-Garcia, J. M.
NEUROLOGY 1997;48:456-464
© 1997 American Academy of Neurology

Dose-dependent, central effects of botulinum neurotoxin type A

A pilot study in the alert behaving cat

B. Moreno-Lopez, BS, A. M. Pastor, PhD, R. R. de la Cruz, PhD and J. M. Delgado-Garcia, MD, PhD

From the Laboratorio de Neurociencia, Facultad de Biologia, Universidad de Sevilla, Sevilla, Spain.
Supported by grants PB93-1175 from the Spanish DGICYT and 3,045 from the Junta de Andalucia, Spain.
Received March 5, 1996. Accepted in final form July 5, 1996.
Address correspondence and reprint requests to Prof Delgado-Garcia, MD, Laboratorio de Neurociencia, Facultad de Biologia, Avda. Reina Mercedes, 6, 41012-Sevilla, Spain.

Article abstract-We investigated, in alert behaving cats, the long-term effects of botulinum neurotoxin (BoNT) type A injected into the lateral rectus muscle of the eye. We studied orthodromic field potentials recorded in the injected muscle, eye movements, and the discharge characteristics of the innervating abducens motoneurons. Single BoNT injections at doses from 0.01 to 0.3 ng/kg reduced, or even completely eliminated, eye movements in the abducting direction for up to 2 months without affecting the motoneuron discharge profile that remained related to actual eye movements of the contralateral unparalyzed eye. This result indicates that abducens motoneurons were still under the influence of the ocular motor central control system regardless of their ineffective action on lateral rectus muscle fibers. We also conclude that paralysis per se is not enough to initiate axotomy-like neural responses in ocular motoneurons. The injection of BoNT at a dose of 3 ng/kg produced significant changes in the discharge pattern of abducens motoneurons lasting up to 3 months-the maximum time checked. This finding was probably due to retrograde and, perhaps, transneuronal effects of BoNT when injected in a high dose. The results give some indications of the maximum allowable dose that can be used without the induction of unwanted side effects in the motoneuronal pool innervating the injected muscle.

NEUROLOGY 1997;48: 456-464




This article has been cited by other articles:


Home page
NeurologyHome page
A. Curra and A. Berardelli
Do the unintended actions of botulinum toxin at distant sites have clinical implications?
Neurology, March 24, 2009; 72(12): 1095 - 1099.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
F. Antonucci, C. Rossi, L. Gianfranceschi, O. Rossetto, and M. Caleo
Long-Distance Retrograde Effects of Botulinum Neurotoxin A
J. Neurosci., April 2, 2008; 28(14): 3689 - 3696.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
I. Ugalde, S. P. Christiansen, and L. K. McLoon
Botulinum Toxin Treatment of Extraocular Muscles in Rabbits Results in Increased Myofiber Remodeling
Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 4114 - 4120.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
G. Schiavo, M. Matteoli, and C. Montecucco
Neurotoxins Affecting Neuroexocytosis
Physiol Rev, April 1, 2000; 80(2): 717 - 766.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
G. PAVESI, R. BRIANTI, D. MEDICI, P. MAMMI, A. MAZZUCCHI, and D. MANCIA
Botulinum toxin type A in the treatment of upper limb spasticity among patients with traumatic brain injury
J. Neurol. Neurosurg. Psychiatry, March 1, 1998; 64(3): 419 - 420.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by AAN Enterprises, Inc.